MED-EL USA Presents Single-Sided Deafness, Tailored Solutions at 2025 American Cochlear Implant Association Meeting

April 23, 2025 – DURHAM, NC – Hearing implant leader MED-EL USA is announcing two upcoming symposia at CI2025, the annual meeting of the American Cochlear Implant Association (ACIA) in Boston. The meeting also celebrates the launch of the recently FDA-approved SONNET 3, the latest audio processor available in the United States.

SONNET 3 supports wireless streaming options without the need for additional devices, as well as a new, flexible ear hook and IP68 waterproof rating. The processor also offers advanced automated audio processing, including ASM 3.0 technology, which adjusts the processor's settings to match the environment.

“ACIA is a great meeting for the cochlear implant community to further the goal of using clinical research to drive evidence-based practice,” said Allison Racey, AuD, Vice President of Clinical Research, MED-EL. “MED-EL supports research aimed to develop and deliver leading-edge technology to restore hearing and empower connection. We’re excited to showcase our dedication to personalized solutions for all cochlear implant candidates, including those with single-sided deafness or residual hearing.”

“MED-EL has a longstanding commitment to science that aims to optimize outcomes and sound quality for cochlear implant recipients. The SONNET 3 technology continues to take advantage of individualized mapping mechanisms and ASM 3.0 features, while addressing key requests from recipients and audiologists alike, including a smaller, more comfortable, and more durable processor design, direct streaming capabilities, and more customization within the programming software for audiologists,” said Amanda D. Sloop, AuD, CCC-A, Research Assistant Professor, University of North Carolina Department of Otolaryngology/Head & Neck Surgery.

Participants are invited to explore how MED-EL’s latest technologies embody the company’s enduring promise to empower clinicians and improve patient care.

“Single-Sided Deafness and MED-EL Cochlear Implants: The Optimal Choice”
Wednesday, April 30, 2025, 2:45-4:00 PM
With an emphasis on patients with single-sided deafness, key symposium topics include the use of OTOPLAN for confident electrode selection and the benefits of streamlined and anatomy-based fitting. Early SONNET 3 user experience will be reviewed.

“Hear Us Out: Expanding Access and Personalizing Cochlear Implant Solutions”
Saturday, May 3, 2025, 7:30-8:30 AM
This symposium highlights innovations that expand access to cochlear implants while tailoring solutions to meet individual needs. It explores how advancements in hearing preservation, outcome optimization, and personalized care address the diverse needs of individuals with varying hearing profiles.

About MED-EL
MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by its mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair. Their ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and became the basis for the modern CI today. The company hired its first employees in 1990 and has since grown to more than 2,900 employees across 90 nations and 30 locations worldwide. The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices. www.medel.com

# # #

MEDIA CONTACT: Rebecca Novak Tibbitt
[email protected]